title: Purification methods: a way to treat severe acute inflammation related to sepsis?
abstract: After numerous negative randomized trials testing drugs for severe sepsis and/or septic shock, the blood purification approach remains one possibility. Many techniques have been proposed, having in common the goal to eliminate blood and/or plasma factors, supposed to play a negative role in outcomes. Among these, high dose of hemofiltration, high volume hemofiltration, high permeability hemofiltration and specific or non-specific hemoperfusion or hemoadsorption have been proposed. Until now, a poor level of proof has been published, questioning the pertinence of such a strategy. To have a chance to succeed, immune monitoring has to be performed to select suitable patients regarding their immune status, the intensity of inflammation and their cellular function. Because of the potential interaction with mediators and cell capture, Rimmelé and colleagues published the results obtained with an in vitro set up, testing different adsorption cartridges in comparison to hemofiltration. They nicely confirmed the complex impact on mediator levels and cell capture and phenotype. This is certainly a more systematic approach to better understand the action of such adsorbing cartridges, which has to be developed.
authors.forename: Anne Claire
authors.initials: AC
authors.lastname: Lukaszewicz
authors.forename: Didier
authors.initials: D
authors.lastname: Payen
mesh_terms: D005112:Extracorporeal Circulation / Q000379:methods*; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology*; D007962:Leukocytes / Q000276:immunology*; D018805:Sepsis / Q000276:immunology* / Q000628:therapy*